SEATTLE, WAS., and MADISON, WIS. – The Jain Foundation, a non-profit organization whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency, today announced the signing of a Master Service Agreement with Cellular Dynamics International (CDI; Nasdaq: ICEL). CDI will create five induced pluripotent stem cell (iPSC) lines from patients with these dystrophies. […]
Strand Life Sciences Private Limited, a global life sciences company headquartered in Bangalore, is collaborating with the San Francisco Bay Area based El Camino Hospital to locate a Strand Center for Genomics and Personalized Medicine at the Genomic Medicine Institute of the El Camino Hospital to accelerate the adoption of next generation sequencing based research […]
PITTSBURGH and SAN DIEGO — ANSYS (NASDAQ: ANSS), a global leader and innovator of engineering simulation software, announced today that it has entered into a definitive merger agreement with Reaction Design, a leading developer of chemistry simulation software. The transaction is expected to close in January 2014. Management will provide further details regarding the transaction […]
OAKLAND, Calif. & SALT LAKE CITY — Omicia, Inc., has announced a partnership with the University of Utah’s Utah Genome Project. Under a two-year licensing agreement with Omicia, the University will use and advance Opal, the company’s whole genome analysis platform for research and clinical applications. The agreement enables the University’s researchers and clinicians to […]
MOUNTAIN VIEW, Calif. — DNAnexus, a pioneer in cloud-based solutions for large-scale DNA data management and analysis, today announced a collaboration with Stanford University that has resulted in a new 1000 Genomes Project data set of genetic variation. Through this collaboration, scientists have analyzed and identified genetic variants in more than 80 terabytes (TB) of […]
LONDON, UK — Leading sample management software provider, Titian Software, has announced that its Mosaic software is to play a central role in compound library screening for a major new European drug discovery initiative, the European Lead Factory (ELF). Following a successful bid to the Innovative Medicines Initiative (IMI), over 8.7m euros has been invested […]
Manassas, VA – ATCC, the premier global biological materials resource and standards organization, and Evercyte GmbH, a proven developer of immortalized human cells, have entered into a strategic partnership to develop and distribute immortalized cell lines that retain key performance characteristics of primary cells. Immortalized primary cell lines enable scientists to have a sufficient supply […]
Basel, Switzerland – Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its successful collaboration with AstraZeneca on data analysis for compound combination experiments. Drug combination studies, which are increasingly used in pre-clinical research, produce large volumes of data with upwards to 200 combinations per experiment. Genedata […]
Minneapolis, MN — ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans. The privately held company is […]
Mississauga, ON — Therapure Biopharma Inc. and Upfront Chromatography A/S have announced today that they have entered into an agreement for Therapure to acquire the assets and associated business related to human plasma fractionation from Upfront. Upfront has developed over the last 15 years, a proprietary protein purification technology, based on Expanded Bed Adsorption (EBA) […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
